Multiple endocrine neoplasia [MEN] syndrome, unspecified
ICD-10 E31.20 is a billable code used to indicate a diagnosis of multiple endocrine neoplasia [men] syndrome, unspecified.
Multiple endocrine neoplasia (MEN) syndrome is a hereditary condition characterized by the development of tumors in multiple endocrine glands. MEN syndromes are classified into types, with MEN type 1 (Wermer's syndrome) and MEN type 2 (Sipple syndrome) being the most recognized. The unspecified designation indicates that the specific type of MEN has not been determined. Patients may experience a variety of symptoms related to hormonal imbalances, including growth abnormalities due to excess hormone production, such as growth hormone from the pituitary gland. Puberty disorders may arise from dysregulation of the hypothalamic-pituitary-gonadal axis, leading to precocious or delayed puberty. Polyglandular dysfunction is common, as multiple glands can be affected, leading to conditions such as hyperparathyroidism, pituitary adenomas, and thyroid tumors. Thymus disorders may also be present, particularly in MEN type 2, where thymic tumors can occur. The complexity of managing these patients lies in the need for regular monitoring and intervention for the various endocrine abnormalities that can arise.
Thorough documentation of hormonal levels, imaging studies, and genetic testing results.
Patients presenting with hyperparathyroidism, thyroid nodules, or pituitary adenomas.
Endocrinologists must document the specific glands involved and any associated symptoms to support the diagnosis.
Detailed family history and genetic testing results to confirm hereditary syndromes.
Patients with a family history of endocrine tumors or syndromes.
Geneticists should ensure that the documentation reflects the hereditary nature of the condition and any counseling provided.
Used to evaluate thyroid function in patients with MEN syndrome.
Document the rationale for testing and any previous results.
Endocrinologists should ensure comprehensive thyroid evaluations are included in the management plan.
E31.20 is used when the specific type of MEN syndrome is not identified. It is crucial for capturing the complexity of the patient's condition and ensuring appropriate management and follow-up.
